Clinical Trial Update: Gemcitabine and S-1 for Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine and S-1 for advanced biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Biliary Tract Neoplasm | Phase 2 | Status: COMPLETED